Departments of Metabolic Medicine.
Amagasaki City Office, Amagasaki, Hyogo Japan.
J Diabetes Investig. 2012 Jun 6;3(3):271-5. doi: 10.1111/j.2040-1124.2011.00180.x.
Aims/Introduction: Pronounced reduction of insulin secretion in response to a rise in glucose level has been reported in Japanese patients compared with Caucasian patients, but the mean body mass index (BMI) is also lower in Japanese patients. As BMI is a determinant of insulin secretion, we examined insulin-secretion capacity in obese and non-obese Japanese patients.
Using the oral glucose tolerance test (OGTT), we estimated the insulin-secreting capacity in obese (BMI ≥ 25) and non-obese (BMI < 25) Japanese patients, including 1848 patients with normal glucose tolerance (NGT), 321 patients with impaired glucose tolerance (IGT) and 69 diabetes (DM) patients.
The insulinogenic index (I.I.), calculated by dividing the increment in serum insulin by the increment in plasma glucose from 0 to 30 min during OGTT, decreased from NGT to IGT and to DM in patients with and without obesity. In patients with NGT, IGT and DM, the I.I. values of obese patients were higher than those of the non-obese patients. The peak of insulin concentration in OGTT appeared at 60 min in NGT and at 120 min in IGT in both obese and non-obese patients, but in DM it was observed at 120 min in obese patients and at 60 min in non-obese patients.
These results show that early-phase insulin secretion in obese Japanese patients is higher than in non-obese patients in all stages of glucose tolerance, and delayed insulin-secretion capacity is also conserved in obese Japanese patients, even in IGT and DM, which is similar to Caucasian patients. (J Diabetes Invest, doi:10.1111/j.2040-1124.2011.00180.x, 2011).
目的/引言:与白种人患者相比,人们已经报道了日本患者在应对血糖升高时胰岛素分泌明显减少的情况,但日本患者的平均体重指数(BMI)也较低。由于 BMI 是胰岛素分泌的决定因素,我们检查了肥胖和非肥胖日本患者的胰岛素分泌能力。
我们使用口服葡萄糖耐量试验(OGTT)来评估肥胖(BMI≥25)和非肥胖(BMI<25)日本患者的胰岛素分泌能力,包括 1848 例糖耐量正常(NGT)患者、321 例糖耐量受损(IGT)患者和 69 例糖尿病(DM)患者。
OGTT 期间 0 至 30 分钟血清胰岛素增加与血浆葡萄糖增加的比值,即胰岛素生成指数(I.I.),在肥胖和非肥胖患者中,从 NGT 到 IGT 再到 DM 逐渐降低。在 NGT、IGT 和 DM 患者中,肥胖患者的 I.I.值高于非肥胖患者。OGTT 中胰岛素浓度的峰值在 NGT 中出现在 60 分钟,在 IGT 中出现在 120 分钟,在肥胖和非肥胖患者中均如此,但在 DM 中,肥胖患者出现在 120 分钟,非肥胖患者出现在 60 分钟。
这些结果表明,在葡萄糖耐量的所有阶段,肥胖日本患者的早期胰岛素分泌均高于非肥胖患者,即使在 IGT 和 DM 中,肥胖日本患者的胰岛素分泌延迟能力也得到保留,这与白种人患者相似。(J Diabetes Invest, doi:10.1111/j.2040-1124.2011.00180.x, 2011)。